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Introduction
According to the International Continence Society (ICS) terminology of 2002, overactive bladder (OAB) is defined as urgency, with or without urgency incontinence, usually with frequency and nocturia, if there is no proven infection or other obvious pathology present. 1 The overall prevalence of OAB was thought to be around 11e16% based on previous studies, and no difference was noted between males and females. 2, 3 This clinical condition not only affects personal hygiene and lifestyle, and impacts quality of life negatively, but also has a multidimensional impact on employment. 4 Macroscopically speaking, this disease also has a considerable economic impact. 5 An initial assessment of OAB including detailed history taking and recording of frequencyevolume chart (FVC), also known as "voiding diaries", is essential for the evaluation and management of OAB. Various versions of FVC are available for patients, and debates still exist on the most optimum duration. Based on the patient group of interest, the recommended number of days in previous studies greatly varied from 1 to >7. 6e8 Most of the FVCs now require patients to record the time and volume of each voiding, whereas some FVCs also require patients to record the time and volume of every drink/food they intake. 9 Such detailed recording is at times a burden that patients must endure, and is especially hard on the elderly or when a patient has to work during the daytime. It is a reasonable postulate that as the duration of FVCs increase, the compliance of patients may decrease and consequently affect reliability. 10 If this is seen in a clinical scenario, it may negatively influence the judgment of clinicians.
Therefore, we suspect that a more simple and convenient measurement, such as the first morning voided volume (FMV), might be a useful alternative to FVC. Thus, we conducted a study to analyze the value of FMV as an evaluation tool for patients with OAB.
Materials and methods
We prospectively recruited patients with OAB symptoms from January 2009 to April 2010. Patients who had urinary tract infection, neurogenic bladder, urinary bladder tumor, vesical stones, and lower urinary tract anatomical anomaly were excluded. Approval was given by the Ethics Committee of our hospital after it reviewed the study protocol, prior to recruitment of the patients (the IRB approval number: 201001032IC). Informed consent to participate was obtained from each patient prior to enrolling. General characteristics including age and gender were recorded. All patients completed a 3-day FVC documenting the voided volumes in each episode, incontinence and urgency episodes, day-and nighttime frequencies, and FMV. The first episode of voiding after getting up in the morning was defined as FMV. Patients with a maximal voided volume of less than 300 mL recorded in the FVC were identified to have a small functional bladder capacity, based on a previous study. 11 All patients completed the Overactive Bladder Symptoms Score (OABSS) questionnaire proposed by Homma et al 12 to evaluate the severity of the OAB symptoms. The OABSS is a four-item questionnaire developed to express OAB symptoms. The maximal scores of each question were 2, 3, 5, and 5, respectively, for the severity of daytime frequency, nighttime frequency, urgency, and urgency incontinence.
All patients also underwent urodynamic studies with either conventional pressure-flow urodynamic study or videourodynamic study. Abdominal pressure was measured using a 24F rectal balloon catheter, intravesical pressure was determined using an 8F transurethral catheter, and the filling cystometrography was performed at a filling rate of 30 mL/minute by injecting warm saline. Videourodynamic study was performed when patients had concomitant voiding symptoms and low urinary flow rate, to identify possible bladder outlet obstruction and localize the point of obstruction.
The correlation between FMV, urodynamic parameters, and symptoms severity was analyzed with Spearman correlation. We also compared the sensitivity and specificity in predicting small functional bladder capacity with FMV and cystometric capacity by using the kappa statistic for agreement with maximal voided volume as the gold standard.
Results
A total 102 patients, 43 males and 59 females, were included in the study. The mean AE standard deviation (SD) age of the patients was 66.8 AE 14.0 years (range: 23e85 years). The cystometry (CMG) capacity, mean FMV, and maximal FMV had a negative correlation with age (p < 0.05). Such findings were not observed between different genders. Tables 1 and 2 list the results of FVC and OABSS. The mean AE SD cystometric capacity was 173.8 AE 108.4 mL (range: 22e600 mL) and the mean AE SD FMV was 196.6 AE 106.5 mL (range: 20e650 mL). The mean FMV was significantly larger than the cystometric capacity (p ¼ 0.03). FMV was equal to the maximum voided volume in 24 patients (23.5%) and was significantly correlated to the cystometric capacity (p ¼ 0.026). We failed to find a significant correlation between FMV and postvoid residual urine volume in this study.
Although there was no significant correlation between FMV and the total score of OABSS (p ¼ 0.424), the cystometric capacity showed negative correlations with the total score of OABSS (p ¼ 0.031) and the subscore for nighttime frequency on the OABSS (p ¼ 0.023). The correlations of the mean FMV with the FVC and other OABSS parameters are summarized in Table 3 . As we can see in the table, the mean FMV had a significant positive correlation to the mean voided volume, and a significant negative correlation to both mean voiding and nighttime frequency. When comparing with the OABSS parameters, we could find only a significant negative correlation between the mean FMV and the mean subscore of nighttime frequency.
Forty-seven patients (46.1%) were classified as having a small functional bladder capacity. The mean AE SD functional bladder capacity was 349.6 AE 146.7 mL (range: 84e1100 mL). Being the single diagnostic tool in predicting small functional bladder capacity, maximal FMV showed its superiority in both sensitivity and specificity as compared to cystometric capacity (100% vs. 95.9% and 43.3% vs. 15.1%, respectively). FMV was shown to have a reasonable agreement with a significant p value (kappa ¼ 0.42 AE 0.08, p < 0.0001), but CMG capacity did not (kappa ¼ 0.096 AE 0.05, p ¼ 0.082). When combining both the mean FMV and the cystometric capacity, the sensitivity and specificity were improved to 95.9% and 50.9%, respectively.
Discussion
As a tool for the initial assessment of patients with OAB, FVCs provide us with objective data that support the evaluation of symptom severity. Various formats of FVCs have been published in various studies, and the most optimal duration remains debatable. The effort required to record each and every voiding episode is labor intensive, and FVCs with longer duration such as 1 week or 2 weeks may inevitably become a burden and decrease compliance rates. Groutz et al 6 published a study and highlighted that as FVC duration increased, the reliability of the testing increased while compliance decreased. In the study reported by Yap et al, 9 they concluded that although they had sufficient reliability to differentiate between high and low levels of voiding symptoms, a 1-day FVC could not be used for the diagnosis of men with lower urinary tract symptoms. Sometimes even when the patient completed the FVC, data from the chart could still not be trusted. A previous study showed that non-Caucasian patients and patients with no urinary symptoms had a lower compliance rate to complete FVC. This finding suggests that socialeeconomic levels and symptom severity may play a role in affecting patients' motivation to complete the FVCs and, to a certain extent, may influence the accuracy and reliability of FVCs. The same study also revealed that despite the low compliance rate, only 71% of patients could complete the FVCs correctly. 13 Thus, the information provided by FVCs should not be considered accurate or complete, especially when reliability is put into question. To obtain useful information from FVCs, given these circumstances, is crucial in our clinical practice; hence, FMV was assessed in our study to evaluate the symptoms in patients with OAB.
We extracted the data of FMV from the FVCs, which is a relatively simple, once-a-day parameter that places less of a burden on patients to record their data. FMV has also been referred to as early morning voiding in other studies. Although there have been few discussions with regard to FMV in adults, previous studies have shown that FMV is related to nocturnal enuresis in pediatric individuals. 14, 15 In previous studies, FMV represented the largest voided volume during a 24-hour voiding period in the majority of individuals examined, either in adults or in children. 11, 14, 16 Evidence suggests that FMV is related to the rest-phase filling of the urinary bladder. Interestingly, we found that FMV showed a significant negative correlation to the nighttime frequency in the present study, reinforcing this point of view. The posture factor might have contributed, in part, to this observed phenomenon. There are studies in the related literature demonstrating decreased cystometric capacity when patients were in a standing position as compared to the supine position. 11 Thus, we suggest that FMV correlates to the functional bladder capacity after patients have been in the supine position during sleep at night. This finding also logically leads to a significantly negative correlation between FMV and OABSS subscore 2, because the question is mainly about nighttime frequency.
A similar negative correlation was also seen between cystometric capacity and nighttime frequency, which was more evident when analyzed with FMV. Considering that there are many factors that may affect the results of cystometric capacity, such as the type of filling materials, filling rate, and temperature of filling materials, this is a reasonable finding because the voiding volume of FMV was contributed by a physiologic method, with a slow rate of urinary bladder filling. In one study evaluating the maximum bladder capacity in females with urinary incontinence, the maximum bladder capacity measured by FVC was significantly higher than that by CMG. 17 A similar finding was also noted in our study, in which FMV was significantly larger than the cystometric capacity.
According to the related literature, normal bladder capacity ranges from 400 mL to 600 mL. 18 Reduced urinary bladder volume sometimes suggests an underlying etiology and as such must be investigated further. There are several possible causes for decreased urinary bladder capacities, such as interstitial cystitis, ketamine cystitis, upper motor neuron lesions, or a contracted bladder wall due to chronic infection. In some unusual cases, a huge urinary bladder tumor may also cause a decrease in functional bladder capacity. Meanwhile, the correlation between OAB and reduced urinary bladder volume is less discussed and yet to be determined, although about 46% of patients in our study were observed to have small-volume bladders. We classified patients with OAB as those with small-volume bladders when the single maximal voided volume recorded in the FVC was less than or equal to 300 mL, as it represents a markedly reduced urinary bladder volume as compared to normal circumstances. An advanced examination, such as cystoscopy, may be needed to identify the potential causes. The cystometric capacity was proved to have moderate sensitivity and specificity in predicting small-volume bladders by Yoon and Swift. 11 However, cystometric capacity showed poor specificity in our study, and different patient groups might play a role in this observation. In this case, our study group focused on patients with OAB, whereas previous studies discussed patients with the primary complaints of urinary incontinence. However, fluctuation of daily FMV is an issue for analysis. In the present study, we collected both the single maximal FMV and the 3-day mean FMV for further analysis, and the single maximal FMV showed better sensitivity and specificity than both the CMG capacity and the mean FMV, with a significant difference. Furthermore, considering the noninvasive characteristics and convenience of FMV, we assumed that the single maximal FMV is a superior prediction tool for the assessment of small-volume bladders in patients with OAB.
In conclusion, FVCs play an important role in evaluating patients with OAB. However, compliance rates and reliability varied in different studies, and determining the most adequate duration and the components in FVC remains debatable. In some circumstances, patients may not complete the chart correctly, and the information from the FVC should be used with caution. FMV is a relatively dependable and easily recorded item in the FVC when the credibility of the chart is put into question. In OAB patients, FMV showed a negative correlation to nighttime frequency and might play a role in evaluating the treatment results. FMV also showed better sensitivity and specificity in predicting small-volume bladders as compared to CMG capacity, while we assume it to be superior to CMG capacity due its noninvasive nature and easy accessibility. The usage of FMV might be extended in the clinical scenario, and further investigations should be considered to better determine its effectiveness.
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